A group of scientists from the laboratory of nanooptics and plasmonics MIPT has developed a chip-based oxide. Its main purpose is to find new drugs to treat cancer, HIV and a host of other dangerous diseases. Now scientists plan to start serial production.
The chip can detect the minimum concentration of substances in biological fluids and to monitor the interaction of molecules in liquid environments.
"With their help, we can trace how this or that chemical reaction can estimate its speed, and thus can accurately determine the effect of a substance on the cell, a pathogenic bacterium. This means that in the near future preclinical trials of drugs may be conducted in a fundamentally new way to predict exactly the effect of the drug, it is enough to observe the interaction of drugs with living tissue directly on the biosensor. This is a revolution in the development of new medicines: biosensors will significantly improve the efficiency of preclinical studies and possibly in the near future will help to win yet incurable disease." says study author Yuri Stebunov
Graphene chips – the next generation of devices for the pharmaceutical and medical industries. Current sensors are made of glass with a thin layer of gold. The sensitivity of graphene chips is much higher, they have a larger area of interaction with matter. The cost of a new version of the sensor, according to scientists, not above previous versions.